News
-
NewAge Industries, Inc.™ Launches Line of AdvantaPure™ Polyethylene Terephthalate Glycol (PETG) Bottles
AdvantaPure's new line of high-clarity PETG bottles for bioprocessing and fluid handling applications is available in 125, 250, 500, 1000, and 2000 mL sizes. -
Alcanza Clinical Research Expands to Arizona with Opening of Phoenix Medical Trials
Purpose-built to support late-stage trials, the Phoenix site expands sponsor access to experienced investigators and diverse patient populations -
$20 Million COVID-19 Testing Fraud Lawsuit Filed Against Sterling Pathology in California
Lawsuit unsealed in Los Angeles Superior Court alleges that Sterling Pathology Medical Corporation and its owner, Dr. Changgao Yang, engaged in a widespread scheme to submit false and fraudulent claims for phantom COVID-19 testing -
Creative Biolabs Advances CMC Frameworks for Next-Generation Live Biotherapeutic Products
As the microbiome therapeutic landscape shifts from laboratory discovery to clinical reality, Creative Biolabs has announced the expansion of its integrated Chemistry, Manufacturing, and Controls (CMC) services. -
Tenghuan Ge, MBA, MS, Celebrated for Expertise in Education
Tenghuan Ge, MBA, MS, is senior project manager at Tulane University -
Marquis Who's Who Honors Tim McDermond, MS, for Expertise in Business Development
Tim McDermond, MS, recognized as the President and Chief Executive Officer of Mast Labs, LLC -
Arthur R. Euler, MD Featured on the Marquis Masters Podcast
Dr. Euler emphasizes the importance of adaptability in the health care field -
Stealth Adapted Viruses Contributing to the Increasing Incidence of Colon Cancers: An Urgent Call for Extended Viral Studies
An Urgent Call for Extended Viral Studies -
Alfa Cytology Advances Animal Models for Cancer Research and Humanized Immune System Mouse Models
Alfa Cytology provides in vivo research support for tumor studies and immunotherapy using cancer animal models and humanized immune system mice. -
From Reactive to Predictable Recruitment: How Earlier, Smarter Intervention Outperforms Total Investment
OMNI CRS survey shows recruitment challenges often surface too late, pointing to a need for earlier, more targeted patient engagement